SAV1, regulated by HERC4, inhibits the proliferation, migration, and invasion of hepatocellular carcinoma
- PMID: 35116265
- PMCID: PMC8799294
- DOI: 10.21037/tcr-20-698
SAV1, regulated by HERC4, inhibits the proliferation, migration, and invasion of hepatocellular carcinoma
Abstract
Background: Hepatic carcinoma is one of the most malignant cancers worldwide. Salvador 1 (SAV1) plays a key role in a variety of human carcinogenesis. This study investigated the role of SAV1 and HERC4 in hepatocellular carcinoma (HCC).
Methods: SAV1 and HERC4 expressions in HCC tissues were examined using RT-qPCR assay. The regulatory effect of HERC4 on SAV1 was verified by co-immunoprecipitation (Co-IP), RT-qPCR, Western blot, and immunofluorescent assays in HEP3B and Huh 7 cell lines. In addition, functional experimental verification was performed through Edu staining, colony formation, and Transwell assay. Finally, Xenograft tumor model was finally used in nude mice.
Results: Clinical features showed significant difference with SAV1 and HERC4 expression. HERC4 was found to be upregulated, while SAV1 was downregulated in HCC. Patients with high HERC4 or low SAV1 had a worse prognosis. Results showed that HERC4 could notably decreased the expression level of SAV1 in HCC cells. Our results showed that overexpression HERC4 could reverse the inhibitory effects of SAV1 on HCC cell proliferation, migration, and invasion. SAV1 overexpression repressed tumor growth and enhance caspase 3 expression.
Conclusion: SAV1 can be directly downregulated by HERC4, indicating that the HERC4/SAV1 axis might have great promise for targeted therapies of HCC.
Keywords: HERC4, Salvador 1 (SAV1); Hepatocellular carcinoma (HCC); invasion; migration.
2021 Translational Cancer Research. All rights reserved.
Conflict of interest statement
Conflicts of Interests: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr-20-698). The authors have no conflicts of interest to declare.
Figures





Similar articles
-
HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells.DNA Cell Biol. 2017 Jun;36(6):490-500. doi: 10.1089/dna.2016.3626. Epub 2017 Apr 21. DNA Cell Biol. 2017. PMID: 28430527
-
miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.BMC Cancer. 2018 Nov 28;18(1):1179. doi: 10.1186/s12885-018-5016-z. BMC Cancer. 2018. PMID: 30486878 Free PMC article.
-
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.Cell Mol Biol Lett. 2021 Nov 27;26(1):49. doi: 10.1186/s11658-021-00295-4. Cell Mol Biol Lett. 2021. PMID: 34837962 Free PMC article.
-
ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.Theranostics. 2021 Apr 3;11(12):5926-5938. doi: 10.7150/thno.56490. eCollection 2021. Theranostics. 2021. PMID: 33897890 Free PMC article.
-
The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.Yonsei Med J. 2019 Oct;60(10):905-913. doi: 10.3349/ymj.2019.60.10.905. Yonsei Med J. 2019. PMID: 31538425 Free PMC article.
Cited by
-
Novel KDM2B/SAV1 Signaling Pathway Promotes the Progression of Gastric Cancer.Genet Res (Camb). 2023 Mar 31;2023:1230182. doi: 10.1155/2023/1230182. eCollection 2023. Genet Res (Camb). 2023. PMID: 37033161 Free PMC article.
-
Small molecule induced STING degradation facilitated by the HECT ligase HERC4.Nat Commun. 2024 May 29;15(1):4584. doi: 10.1038/s41467-024-48922-w. Nat Commun. 2024. PMID: 38811577 Free PMC article.
-
GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis.Acta Pharm Sin B. 2024 Mar;14(3):1222-1240. doi: 10.1016/j.apsb.2023.12.007. Epub 2023 Dec 16. Acta Pharm Sin B. 2024. PMID: 38486990 Free PMC article.
-
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients.Int J Mol Sci. 2024 Jun 22;25(13):6881. doi: 10.3390/ijms25136881. Int J Mol Sci. 2024. PMID: 38999991 Free PMC article.
References
-
- Budny A, Kozlowski P, Kaminska M, et al. Epidemiology and risk factors of hepatocellular carcinoma. Pol Merkur Lekarski 2017;43:133-9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials